Exact Mass: 429.1913
Exact Mass Matches: 429.1913
Found 500 metabolites which its exact mass value is equals to given mass value 429.1913
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
7-Benzylidenenaltrexone
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
Pizotifen malate
Pizotifen malate (Pizotyline malate) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.
Abiraterone sulfate
Abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)
7-Benzylidenenaltrexone
Azeloprazole
Guan-fu base A
Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2]. Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2].
Hippuryl-histidyl-leucine
2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid
Sarpogrelate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
8-Benzylcanadine
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.163 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.170
2-amino-3-[[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid
(-)-trans-2-fluorocyclohexyl-N-[p-(4-methyl-beta-D-glucopyranosyl)]phenyl-carbamate
7beta-senecioyloxy-9-(5-senecioyloxy angeloyloxy)-5,8-dehydroheliotridin-5-one|7beta-senecioyloxy-9-<5-senecioyloxy angeloyloxy>-5,8-dehydroheliotridin-5-one
(-)N-(12-Acetoxy)jasmonoyl-phenylalaninmethylester
acehytisine
Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2]. Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2].
C21H35NO6S_Cysteine, S-[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxooxacyclotetradeca-6,9-dien-4-yl]
2-amino-3-[[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid_major
Ala Asp Lys Pro
Ala Asp Pro Lys
Ala Asp Pro Gln
Ala Asp Gln Pro
Ala Glu Asn Pro
Ala Glu Pro Asn
Ala Gly Pro Trp
Ala Gly Trp Pro
Ala Lys Asp Pro
Ala Lys Pro Asp
Ala Asn Glu Pro
Ala Asn Pro Glu
Ala Pro Asp Lys
Ala Pro Asp Gln
Ala Pro Glu Asn
Ala Pro Gly Trp
Ala Pro Lys Asp
Ala Pro Asn Glu
Ala Pro Gln Asp
Ala Pro Trp Gly
Ala Gln Asp Pro
Ala Gln Pro Asp
Ala Trp Gly Pro
Ala Trp Pro Gly
Cys Asn Pro Pro
Cys Pro Asn Pro
Cys Pro Pro Asn
Asp Ala Lys Pro
Asp Ala Pro Lys
Asp Ala Pro Gln
Asp Ala Gln Pro
Asp Lys Ala Pro
Asp Lys Pro Ala
Asp Pro Ala Lys
Asp Pro Ala Gln
Asp Pro Lys Ala
Asp Pro Gln Ala
Asp Gln Ala Pro
Asp Gln Pro Ala
Glu Ala Asn Pro
Glu Ala Pro Asn
Glu Gly Lys Pro
Glu Gly Pro Lys
Glu Gly Pro Gln
Glu Gly Gln Pro
Glu Lys Gly Pro
Glu Lys Pro Gly
Glu Asn Ala Pro
Glu Asn Pro Ala
Glu Pro Ala Asn
Glu Pro Gly Lys
Glu Pro Gly Gln
Glu Pro Lys Gly
Glu Pro Asn Ala
Glu Pro Gln Gly
Glu Gln Gly Pro
Glu Gln Pro Gly
Gly Ala Pro Trp
Gly Ala Trp Pro
Gly Glu Lys Pro
Gly Glu Pro Lys
Gly Glu Pro Gln
Gly Glu Gln Pro
Gly Lys Glu Pro
Gly Lys Pro Glu
Gly Pro Ala Trp
Gly Pro Glu Lys
Gly Pro Glu Gln
Gly Pro Lys Glu
Gly Pro Gln Glu
Gly Pro Trp Ala
Gly Gln Glu Pro
Gly Gln Pro Glu
Gly Trp Ala Pro
Gly Trp Pro Ala
Ile Asn Pro Ser
Ile Asn Ser Pro
Ile Pro Asn Ser
Ile Pro Ser Asn
Ile Ser Asn Pro
Ile Ser Pro Asn
Lys Ala Asp Pro
Lys Ala Pro Asp
Lys Asp Ala Pro
Lys Asp Pro Ala
Lys Glu Gly Pro
Lys Glu Pro Gly
Lys Gly Glu Pro
Lys Gly Pro Glu
Lys Pro Ala Asp
Lys Pro Asp Ala
Lys Pro Glu Gly
Lys Pro Gly Glu
Leu Asn Pro Ser
Leu Asn Ser Pro
Leu Pro Asn Ser
Leu Pro Ser Asn
Leu Ser Asn Pro
Leu Ser Pro Asn
Asn Ala Glu Pro
Asn Ala Pro Glu
Asn Cys Pro Pro
Asn Glu Ala Pro
Asn Glu Pro Ala
Asn Ile Pro Ser
Asn Ile Ser Pro
Asn Leu Pro Ser
Asn Leu Ser Pro
Asn Pro Ala Glu
Asn Pro Cys Pro
Asn Pro Glu Ala
Asn Pro Ile Ser
Asn Pro Leu Ser
Asn Pro Pro Cys
Asn Pro Ser Ile
Asn Pro Ser Leu
Asn Pro Thr Val
Asn Pro Val Thr
Asn Ser Ile Pro
Asn Ser Leu Pro
Asn Ser Pro Ile
Asn Ser Pro Leu
Asn Thr Pro Val
Asn Thr Val Pro
Asn Val Pro Thr
Asn Val Thr Pro
Pro Ala Asp Lys
Pro Ala Asp Gln
Pro Ala Glu Asn
Pro Ala Gly Trp
Pro Ala Lys Asp
Pro Ala Asn Glu
Pro Ala Gln Asp
Pro Ala Trp Gly
Pro Cys Asn Pro
Pro Cys Pro Asn
Pro Asp Ala Lys
Pro Asp Ala Gln
Pro Asp Lys Ala
Pro Asp Gln Ala
Pro Glu Ala Asn
Pro Glu Gly Lys
Pro Glu Gly Gln
Pro Glu Lys Gly
Pro Glu Asn Ala
Pro Glu Gln Gly
Pro Gly Ala Trp
Pro Gly Glu Lys
Pro Gly Glu Gln
Pro Gly Lys Glu
Pro Gly Gln Glu
Pro Gly Trp Ala
Pro Ile Asn Ser
Pro Ile Ser Asn
Pro Lys Ala Asp
Pro Lys Asp Ala
Pro Lys Glu Gly
Pro Lys Gly Glu
Pro Leu Asn Ser
Pro Leu Ser Asn
Pro Asn Ala Glu
Pro Asn Cys Pro
Pro Asn Glu Ala
Pro Asn Ile Ser
Pro Asn Leu Ser
Pro Asn Pro Cys
Pro Asn Ser Ile
Pro Asn Ser Leu
Pro Asn Thr Val
Pro Asn Val Thr
Pro Pro Cys Asn
Pro Pro Asn Cys
Pro Gln Ala Asp
Pro Gln Asp Ala
Pro Gln Glu Gly
Pro Gln Gly Glu
Pro Gln Ser Val
Pro Gln Val Ser
Pro Ser Ile Asn
Pro Ser Leu Asn
Pro Ser Asn Ile
Pro Ser Asn Leu
Pro Ser Gln Val
Pro Ser Val Gln
Pro Thr Asn Val
Pro Thr Val Asn
Pro Val Asn Thr
Pro Val Gln Ser
Pro Val Ser Gln
Pro Val Thr Asn
Pro Trp Ala Gly
Pro Trp Gly Ala
Gln Ala Asp Pro
Gln Ala Pro Asp
Gln Asp Ala Pro
Gln Asp Pro Ala
Gln Glu Gly Pro
Gln Glu Pro Gly
Gln Gly Glu Pro
Gln Gly Pro Glu
Gln Pro Ala Asp
Gln Pro Asp Ala
Gln Pro Glu Gly
Gln Pro Gly Glu
Gln Pro Ser Val
Gln Pro Val Ser
Gln Ser Pro Val
Gln Ser Val Pro
Gln Val Pro Ser
Gln Val Ser Pro
Ser Ile Asn Pro
Ser Ile Pro Asn
Ser Leu Asn Pro
Ser Leu Pro Asn
Ser Asn Ile Pro
Ser Asn Leu Pro
Ser Asn Pro Ile
Ser Asn Pro Leu
Ser Pro Ile Asn
Ser Pro Leu Asn
Ser Pro Asn Ile
Ser Pro Asn Leu
Ser Pro Gln Val
Ser Pro Val Gln
Ser Gln Pro Val
Ser Gln Val Pro
Ser Val Pro Gln
Ser Val Gln Pro
Thr Asn Pro Val
Thr Asn Val Pro
Thr Pro Asn Val
Thr Pro Val Asn
Thr Val Asn Pro
Thr Val Pro Asn
Val Asn Pro Thr
Val Asn Thr Pro
Val Pro Asn Thr
Val Pro Gln Ser
Val Pro Ser Gln
Val Pro Thr Asn
Val Gln Pro Ser
Val Gln Ser Pro
Val Ser Pro Gln
Val Ser Gln Pro
Val Thr Asn Pro
Val Thr Pro Asn
Trp Ala Gly Pro
Trp Ala Pro Gly
Trp Gly Ala Pro
Trp Gly Pro Ala
Trp Pro Ala Gly
Trp Pro Gly Ala
2-(4-methylpiperidin-1-yl)ethyl 6-ethyl-3-methyl-2,9-dioxo-[1,3]thiazolo[5,4-f]quinoline-8-carboxylate
2-hydroxyethyl 2-methylprop-2-enoate,2-methylidenehexanoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid
(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID
3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole
2-(((1-(TERT-BUTOXY)-2-METHYL-1-OXOPROPAN-2-YL)OXY)IMINO)-2-(2-((TERT-BUTOXYCARBONYL)AMINO)THIAZOL-4-YL)ACETIC ACID
2-(2-ETHOXY-1-BUTENYL)-5-PHENYL-3-(3-SULFOBUTYL)BENZOXAZOLIUM INNER SALT
4-[BUTYL([2-(1H-TETRAZOL-5-YL)[1,1-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methylphenyl)-N-(3-pyridinylmethyl)- (9CI)
methyl 1-[(2-carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate
3-{2-[4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
Evobrutinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent
7-[2(S)-[3(R)-Hydroxy-4-[3-(trifluoromethyl)phenyl]butyl]-5-oxopyrrolidin-1-yl]heptanoic acid
17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlori de dihydrate
3,8-DI-(ETHOXYCARBONYLAMINO)-6-PHENYLPHENANTHRIDINE
2-(((4-(2,2-dimethyl-1,3-dioxan-5-yl)methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole
6-[2-Oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-(phenylmethyl)-7-triazolo[4,5-d]pyrimidinone
2-{[(6-Oxo-1,6-Dihydropyridin-3-Yl)methyl]amino}-N-[4-Propyl-3-(Trifluoromethyl)phenyl]benzamide
Sarpogrelate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
(6E)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
2-Amino-6-ethyl-4-(4-methoxyphenyl)-8-[(4-methoxyphenyl)methyl]-4,5-dihydropyrano[3,2-c]pyridine-3-carbonitrile
2-[[4-(4-fluorophenyl)-5-[(1-methyl-2-pyrrolyl)methyl]-1,2,4-triazol-3-yl]thio]-N-(2-oxolanylmethyl)acetamide
N-(2-ethylphenyl)-2-[[2-(4-methoxyphenyl)-4-oxo-1-benzopyran-6-yl]oxy]acetamide
1-acetyl-6-[2-(4-ethyl-1-piperazinyl)-2-oxoethoxy]-4-spiro[3,4-dihydro-2H-1-benzopyran-2,4-piperidine]one
N-[2-methoxy-5-(3-methyl-4-oxo-1-phthalazinyl)phenyl]-2-(4-methylphenoxy)acetamide
N-[3-chloro-4-[4-[oxo-(4-propoxyphenyl)methyl]-1-piperazinyl]phenyl]propanamide
1-[2-[[4,6-Bis(4-morpholinyl)-1,3,5-triazin-2-yl]oxy]ethyl]-3-phenylurea
2-[[(4-ethoxyphenyl)-oxomethyl]amino]acetic acid [2-(9H-fluoren-3-yl)-2-oxoethyl] ester
N-[1-methyl-2-[2-(4-phenyl-1-piperazinyl)ethyl]-5-benzimidazolyl]-2-furancarboxamide
4-[[[2-(1-Azepanyl)ethyl-(2-furanylmethyl)amino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(4-morpholinyl)phenyl]-3-imidazo[1,2-a]pyrazinamine
2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide
1-methyl-4-[2-oxo-2-(N-(phenylmethyl)anilino)ethyl]-5-pyrrolo[3,2-b]pyrrolecarboxylic acid propan-2-yl ester
3-[(2S,4S)-2-(4-hydroxybutoxy)-6-[4-morpholinyl(oxo)methyl]-3,4-dihydro-2H-pyran-4-yl]-1-benzopyran-4-one
(12S,13R,16R,8S)-13-methoxy-6,8,10-trimethyl-5,9-dioxo-13,14,15,16-tetrahydro-12H-3-oxa-6,10-diaza-1(2,6)-pyrana-4(1,2)-benzenacyclododecaphane-44-carbonitrile
(12S,13R,16R,8S)-13-methoxy-6,8,10-trimethyl-5,9-dioxo-13,14,15,16-tetrahydro-12H-3-oxa-6,10-diaza-1(2,6)-pyrana-4(1,2)-benzenacyclododecaphane-46-carbonitrile
(4As,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
(1S,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,9S,10S,11S)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
4-[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
(1R,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,9R,10R,11R)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2S)-2-[(4S,5S)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
(1R,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,13S,18R,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13R,18R,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13R,18S,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13S,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1S,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1S,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
[(1S,2aS,8bS)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone
(2R)-2-[(4S,5S)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
(1R,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
[(1R,2aR,8bR)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone
[(1S,2aR,8bR)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone
[(1R,2aS,8bS)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone
(1S,9R,10R,11R)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
3-[4-[(1S,5R)-3-[(2-fluorophenyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
(3S,12Z)-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-1(15),8,12,17(26),18(23),19,24-heptaene-4,10-dione
(3S,12Z)-14,14,21,21-tetramethyl-20-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.019,24]hexacosa-1(15),8,12,17(26),18,22,24-heptaene-4,10-dione
2-amino-3-[[(6Z,9Z)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid
[(8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulate
4F 4PP (oxalate)
4F 4PP (oxalate) is a selective 5-HT2A antagonist with almost as high affinity (Ki= 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki= 620 nM)[1][2][3][4].
BML-280
BML-280 (VU0285655-1) is a potent and selective phospholipase D2 (PLD2) inhibitor. BML-280 has the ability to prevent caspase-3 cleavage and reduction in cell viability induced by high glucose. BML-280 can be used for rheumatoid arthritis research[1][2].
GNE-9278
GNE-9278 is a highly selective positive allosteric modulator of NMDAR that acts at the GluN1 transmembrane domain (TMD). GNE-9278 acts on activated NMDARs to increase peak current and agonist affinity[1].